Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: A phase I, multicentre, double-blind randomised study

Joan T. Merrill, Daniel J. Wallace, Michelle Petri, Kyriakos A. Kirou, Yihong Yao, Wendy I. White, Gabriel Robbie, Robert Levin, Seth M. Berney, Vishala Chindalore, Nancy Olsen, Laura Richman, Chenxiong Le, Bahija Jallal, Barbara White

Research output: Contribution to journalArticlepeer-review

204 Scopus citations

Fingerprint

Dive into the research topics of 'Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: A phase I, multicentre, double-blind randomised study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds